Mike Ouimette, General Counsel & Corporate Sec'y at PLIANT THERAPEUTICS, INC. (PLRX), sold 33,730 shares at $11.20 ($373K) on 2025-01-17, disclosed to the SEC on 2025-01-22.
Scheduled sale ($373k) by General Counsel & Corporate Sec'y under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.20 | 13,270 | $149K | 39.8% |
| 2 | $10.99 | 10,230 | $112K | 30.1% |
| 3 | $10.99 | 10,230 | $112K | 30.1% |
| Total | $11.07 avg | 33,730 | $373K | 100% |
| Filing → |
| PLRX | SELL | 2023-07-21 | $167K | — | Filing → |
| PLRX | SELL | 2023-07-19 | $460K | — | Filing → |
| PLRX | SELL | 2023-04-03 | $407K | — | Filing → |